Join
Live feed
·
PRReleasevia Quantisnow
Salarius Pharmaceuticals Inc. logo

Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform

ByQuantisnow·Wall Street's wire, on your screen.
SLRX· Salarius Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLRX (Salarius Pharmaceuticals Inc.) and more on Quantisnow.